Risk of second cancer in patients with hairy cell leukemia: Long-term follow-up

Journal of Clinical Oncology

Volumn 20, Issue 3, 2002, Pages 638-646

  Federico, Massimo ^a   Luigi Zinzani, Pier ^a   Frassoldati, Antonio ^a   Vinceti, Marco ^a   Modè, Alessia ^a   Annino, Luciana ^a   Chisesi, Teodoro ^a   Pagnucco, Guido ^a   Invernizzi, Rosangela ^a   Spriano, Mauro ^a   Resegotti, Luigi ^a   Bendandi, Maurizio ^a   Damasio, Eugenio E ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; INTERFERON; PURINE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; FEMALE; FOLLOW UP; HAIRY CELL LEUKEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; SKIN CANCER; SPLENECTOMY; TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERONS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY;

EID: 0036467659     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.3.638     Document Type: Article

References (43)

1. Leukemic reticuloendotheliosis (hairy cell leukemia)
2. Epidemiology of Hairy Cell Leukemia in Los Angeles County
3. Splenectomy in hairy cell leukemia: A retrospective multicenter analysis
4. Response to splenectomy in 65 patients with hairy cell leukemia: An evaluation of spleen weight and bone marrow involvement
5. Splenectomy for hairy cell leukemia: A clinical review of 63 patients
6. Alpha interferon for induction of remission in hairy cell leukemia
7. Interferon treatment for hairy cell leukemia: An update on a cohort of 69 patients treated from 1983-86
8. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alpha-2a
9. Hairy cell leukemia: A clinical review based on 725 cases of the Italian cooperative group (ICGHCL)
10. Human lymphoblastoid alpha-interferon for hairy cell leukemia: An update of the Italian cooperative group
11. Splenectomy after initial therapy with alpha-IFN in patients with hairy cell leukemia: A multicenter study by the Italian Cooperative group for HCLPreliminary results
12. Long-term follow-up of patients with hairy cell leukemia after treatment with 2-deoxycoformycin
13. Remission in hairy cell leukemia with pentostatin (2-deoxycoformycin)
14. Durable complete remission after 2-deoxicoformycin treatment in patients with hairy cell leukemia resistant to interferon-alpha
15. Long-term outcome of patients with hairy cell leukemia treated with pentostatin
16. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin
17. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine
18. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)
19. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia
20. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment
21. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the group C protocol mechanism of the National Cancer Institute: A report of 979 patients
22. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: Long-term follow-up of the Northwestern experience
23. Treatment of hairy cell leukemia: Current views
24. Leukemic reticuloendotheliosis
25. Second malignancies in hairy cell leukemia
26. Second malignancies in patients with hairy cell leukemia in British Columbia: A 20-years experience
27. Second malignancies in hairy cell leukemia (leukemic reticuloendotheliosis)
28. Increased incidence of second neoplasms in patients treated with interferon alpha-2b for hairy cell leukemia: A clinicopathologic assessment
29. Second cancer risk after interferon therapy?
30. Second cancer risk in hairy cell leukemia: Analysis of 350 patients
31. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
32. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia
33. Leukemic reticuloendotheliosis: A failure of monocyte production
34. Normal humoral immunity in hairy cell leukemia
35. Infections in hairy cell leukemia: Clinical evidence of a pronounced defect in cell-mediated immunity
36. Mechanism accounting for the defective natural killer activity in patients with hairy cell leukemia
37. Decrease of memory T helper cells (CD4+ CD45R0+) in hairy cell leukemia
38. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia
39. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia
40. T-cell dysfunction in hairy cell leukemia: An updated review
41. Observations on the development of T-cell leukemia in the patient successfully treated by interferon-alpha for typical hairy cell leukemia (HCL)
42. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia